Methylation of RNA N6-methyladenosine in modulation of cytokine responses and tumorigenesis.

Abstract

Among myriads of distinct chemical modification in RNAs, the dynamic, reversible and fine-tuned methylation of N6-methyladenosine (m6A) is the most prevalent modification in eukaryotic mRNAs. This RNA mark is generated by proteins that act as m6A writers and can be reversed by proteins that act as m6A erasers. The RNA m6A modification is also mediated by another group of proteins capable of recognizing m6A that act as m6A readers. The m6A modification exerts direct control over the RNA metabolism including mRNA processing, mRNA exporting, translation initiation, mRNA stability and the biogenesis of long-non-coding RNA (LncRNA), thereby can influence various aspects of cell function. Evidently, m6A is intimately associated with cancer development and progression such as self-renewal capacity of cancer stem cells, proliferation, apoptosis and therapeutic resistance, and immune response. In this review, we will discuss the regulation and function of m6A, the various functions ascribed to these proteins and the emerging concepts that impact our knowledge of these proteins and their roles in the epitranscriptome. Conceivably, m6A may play pivotal roles in cytokine and immune response and carcinogenesis.

• Authors: Guoqiang Chang, Jia-Shiun Leu, Li Ma, Keping Xie, Suyun Huang
• Journal: Cytokine (Cytokine) Vol. 118 Pg. 35-41 (06 2019) ISSN: 1096-0023 [Electronic] England
• PMID: 30017390 (Publication Type: Journal Article, Review)
• Copyright: Copyright © 2018 Elsevier Ltd. All rights reserved.

Chemical References

• Cytokines
• RNA
• N-methyladenosine
• Adenosine

Topics

• Adenosine (analogs & derivatives, metabolism)
• Animals
• Carcinogenesis (metabolism, pathology)
• Cytokines (metabolism)
• Humans
• Methylation
• Neoplasms (metabolism, pathology)
• RNA (metabolism)